Literature DB >> 427008

Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.

J D Wilson, D J King, B Sheridan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427008      PMCID: PMC1429494          DOI: 10.1111/j.1365-2125.1979.tb00939.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  A simple and reliable subclassification of chronic schizophrenia.

Authors:  J K WING
Journal:  J Ment Sci       Date:  1961-09

2.  Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms.

Authors:  E C Johnstone; T J Crow; K Mashiter
Journal:  Psychol Med       Date:  1977-05       Impact factor: 7.723

3.  Prolactin secretion by metoclopramide in man.

Authors:  S J Judd; L Lazarus; G Smythe
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

4.  Central dopamine turnover in schizophrenic syndromes.

Authors:  M B Bowers
Journal:  Arch Gen Psychiatry       Date:  1974-07

5.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

6.  Effects of alpha- and beta-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrhea.

Authors:  J A Board; R J Fierro; A J Wasserman; A S Bhatnagar
Journal:  Am J Obstet Gynecol       Date:  1977-02-01       Impact factor: 8.661

7.  Decrease in serum-prolactin after propranolol in schizophrenia.

Authors:  T Hanssen; T Heyden; I Sundberg; L Wetterberg; P Eneroth
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

8.  Propranolol in schizophrenia.

Authors:  A P Ridges; K Lawton; P Harper; C Ghosh; N Hindson
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

9.  Schizophrenia as dopamine-deficiency disease.

Authors:  G Chouinard; B D Jones
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

  9 in total
  3 in total

1.  Use of beta-blocking drugs in psychiatry and neurology.

Authors:  P J Tyrer
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  The effect of propranolol on CSF amine metabolites in psychiatric patients.

Authors:  D J King; S J Cooper; J Liddle
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.